Free Trial

Greater Cannabis (GCAN) Competitors

Greater Cannabis logo
$0.0002 0.00 (0.00%)
As of 07/25/2025 01:38 PM Eastern

GCAN vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CALA

Should you be buying Greater Cannabis stock or one of its competitors? The main competitors of Greater Cannabis include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry.

Greater Cannabis vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Greater Cannabis (NASDAQ:GCAN) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Greater CannabisN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Greater Cannabis N/A N/A N/A

In the previous week, 180 Life Sciences had 1 more articles in the media than Greater Cannabis. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Greater Cannabis. 180 Life Sciences' average media sentiment score of 1.89 beat Greater Cannabis' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Very Positive
Greater Cannabis Neutral

Summary

180 Life Sciences beats Greater Cannabis on 2 of the 2 factors compared between the two stocks.

Get Greater Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for GCAN and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GCAN vs. The Competition

MetricGreater CannabisDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.18B$5.73B$9.53B
Dividend YieldN/A2.92%4.69%4.01%
P/E RatioN/A4.2328.4120.07
Price / SalesN/A587.23392.1370.37
Price / CashN/A10.3536.1858.54
Price / BookN/A11.038.655.87
Net IncomeN/A$21.15B$3.25B$258.89M
7 Day PerformanceN/A1.91%4.30%3.76%
1 Month PerformanceN/A6.12%11.60%12.29%
1 Year PerformanceN/A3.01%35.38%17.86%

Greater Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GCAN
Greater Cannabis
N/A$0.00
flat
N/A-71.4%$0.00N/A0.001
ATNFW
180 Life Sciences
N/A$0.01
-21.3%
N/A+21.0%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.16
-4.3%
N/A+95.0%$0.00$106.21K0.0040Positive News
Gap Up
ALVOW
Alvotech
N/A$1.95
+6.0%
N/A+2.7%$0.00$585.60M0.004Positive News
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/A-37.0%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.10
-2.8%
N/AN/A$0.00$38.00M0.0070Gap Down
BTMDW
biote
N/A$0.01
+10.4%
N/A-97.6%$0.00$199.38M0.00N/AHigh Trading Volume
BCTXW
BriaCell Therapeutics
N/A$0.07
+1.6%
N/A-79.9%$0.00N/A0.008
CALA
Calithera Biosciences
N/A$0.00
flat
N/A-99.2%$0.00N/A0.0060

Related Companies and Tools


This page (NASDAQ:GCAN) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners